Resistance to TKIs in EGFR-Mutated Non-Small Cell Lung Cancer: From Mechanisms to New Therapeutic Strategies.
EGFR
TKIs
immunotherapy
non-small cell lung cancer
osimertinib
resistance
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
08 Jul 2022
08 Jul 2022
Historique:
received:
10
04
2022
revised:
25
06
2022
accepted:
06
07
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
28
7
2022
Statut:
epublish
Résumé
Resistance to tyrosine kinase inhibitors (TKIs) of the epidermal growth factor receptor (EGFR) in advanced mutant Non-Small Cell Lung Cancer (NSCLC) constitutes a therapeutic challenge. This review intends to summarize the existing knowledge about the mechanisms of resistance to TKIs in the context of EGFR mutant NSCLC and discuss its clinical and therapeutic implications. EGFR-dependent and independent molecular pathways have the potential to overcome or circumvent the activity of EGFR-targeted agents including the third-generation TKI, osimertinib, negatively impacting clinical outcomes. CNS metastases occur frequently in patients on EGFR-TKIs, due to the inability of first and second-generation agents to overcome both the BBB and the acquired resistance of cancer cells in the CNS. Newer-generation TKIs, TKIs targeting EGFR-independent resistance mechanisms, bispecific antibodies and antibody-drug conjugates or combinations of TKIs with other TKIs or chemotherapy, immunotherapy and Anti-Vascular Endothelial Growth Factors (anti-VEGFs) are currently in use or under investigation in EGFR mutant NSCLC. Liquid biopsies detecting mutant cell-free DNA (cfDNA) provide a window of opportunity to attack mutant clones before they become clinically apparent. Overall, EGFR TKIs-resistant NSCLC constitutes a multifaceted therapeutic challenge. Mapping its underlying mutational landscape, accelerating the detection of resistance mechanisms and diversifying treatment strategies are essential for the management of the disease.
Identifiants
pubmed: 35884398
pii: cancers14143337
doi: 10.3390/cancers14143337
pmc: PMC9320011
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Expert Rev Anticancer Ther. 2022 Jan;22(1):3-16
pubmed: 34913823
Onco Targets Ther. 2021 Mar 31;14:2301-2309
pubmed: 33833528
Lung Cancer. 2018 Dec;126:149-155
pubmed: 30527179
Ann Oncol. 2017 Oct 01;28(10):2451-2457
pubmed: 28961841
N Engl J Med. 2020 Feb 13;382(7):610-621
pubmed: 31825192
Front Oncol. 2021 Apr 26;11:642190
pubmed: 33981604
Ann Oncol. 2015 Oct;26(10):2073-8
pubmed: 26269204
N Engl J Med. 2005 Jul 14;353(2):123-32
pubmed: 16014882
Cancer Biol Ther. 2016 Apr 2;17(4):407-13
pubmed: 26954523
Front Pharmacol. 2021 Jul 12;12:702445
pubmed: 34322025
N Engl J Med. 2018 Jun 14;378(24):2288-2301
pubmed: 29863955
Science. 2011 Mar 25;331(6024):1565-70
pubmed: 21436444
Oncotarget. 2017 Mar 14;8(11):18609-18614
pubmed: 28061471
J Clin Oncol. 2013 Jun 1;31(16):1997-2003
pubmed: 23610105
Ann Oncol. 2013 Apr;24(4):993-9
pubmed: 23129122
J Thorac Dis. 2018 May;10(Suppl 13):S1556-S1563
pubmed: 29951306
Int J Mol Sci. 2022 May 19;23(10):
pubmed: 35628495
Lung Cancer. 2021 Sep;159:18-26
pubmed: 34303276
Biomed Res Int. 2018 Mar 11;2018:9010353
pubmed: 29713646
Cancer Discov. 2022 Jan;12(1):74-89
pubmed: 34548309
Lung Cancer. 2021 Mar;153:126-133
pubmed: 33486418
Clin Cancer Res. 2016 Sep 15;22(18):4585-93
pubmed: 27225694
Biochem Biophys Res Commun. 2014 Mar 28;446(1):179-86
pubmed: 24582749
Oncogene. 2019 Nov;38(47):7197-7199
pubmed: 31616060
J Clin Oncol. 2017 Apr 20;35(12):1288-1296
pubmed: 28221867
Clin Cancer Res. 2016 Oct 15;22(20):5130-5140
pubmed: 27435396
Lancet. 2016 Apr 9;387(10027):1540-1550
pubmed: 26712084
J Thorac Oncol. 2015 Dec;10(12):1736-44
pubmed: 26473643
Clin Cancer Res. 2015 Sep 1;21(17):3913-23
pubmed: 25948633
Lancet Respir Med. 2019 May;7(5):387-401
pubmed: 30922878
Cancer Discov. 2021 Jul;11(7):1688-1699
pubmed: 33632775
Sci Rep. 2018 Feb 22;8(1):3466
pubmed: 29472634
Lung Cancer. 2019 Jan;127:146-152
pubmed: 30642543
J Thorac Oncol. 2016 Mar;11(3):414-9
pubmed: 26723242
J Thorac Oncol. 2019 Oct;14(10):e220-e221
pubmed: 31558231
Ann Oncol. 2020 Oct;31(10):1397-1404
pubmed: 32634610
Lancet Oncol. 2017 Nov;18(11):1454-1466
pubmed: 28958502
J Thorac Oncol. 2018 Aug;13(8):1222-1226
pubmed: 29702285
Eur J Cancer. 2020 Jan;124:110-122
pubmed: 31760310
Nat Commun. 2018 Nov 7;9(1):4655
pubmed: 30405134
J Clin Oncol. 2018 Aug 28;:JCO2018783118
pubmed: 30153097
Cancer Discov. 2019 Jul;9(7):926-943
pubmed: 31092401
J Thorac Oncol. 2016 Oct;11(10):1718-28
pubmed: 27237825
Pharmgenomics Pers Med. 2014 Sep 19;7:285-95
pubmed: 25278773
Future Oncol. 2022 Feb;18(6):639-647
pubmed: 34911336
Transl Lung Cancer Res. 2020 Aug;9(4):1258-1267
pubmed: 32953503
N Engl J Med. 2020 Sep 3;383(10):931-943
pubmed: 32469185
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Signal Transduct Target Ther. 2019 Mar 8;4:5
pubmed: 30854234
Clin Cancer Res. 2013 Apr 15;19(8):2240-7
pubmed: 23470965
Nat Commun. 2022 May 9;13(1):2530
pubmed: 35534503
J Clin Oncol. 2021 Oct 20;39(30):3391-3402
pubmed: 34339292
Ann Oncol. 2019 May 1;30(5):839-844
pubmed: 30847464
N Engl J Med. 2020 Sep 3;383(10):944-957
pubmed: 32877583
Curr Oncol. 2018 Jun;25(Suppl 1):S28-S37
pubmed: 29910645
N Engl J Med. 2018 Jan 11;378(2):113-125
pubmed: 29151359
J Clin Oncol. 2018 Mar 20;36(9):841-849
pubmed: 28841389
Cells. 2021 May 14;10(5):
pubmed: 34069119
Nat Cancer. 2021 Apr;2(4):377-391
pubmed: 35122001
Case Rep Oncol. 2018 May 29;11(2):323-329
pubmed: 29928211
Clin Cancer Res. 2018 Dec 15;24(24):6195-6203
pubmed: 30228210
J Thorac Oncol. 2018 Oct;13(10):1560-1568
pubmed: 29981927
Ann Oncol. 2020 Feb;31(2):191-201
pubmed: 31959336
Arch Med Sci. 2018 Oct;14(6):1298-1307
pubmed: 30393484
Cancer Res. 2008 May 1;68(9):3077-80; discussion 3080
pubmed: 18451130
Sci Rep. 2021 Sep 21;11(1):18762
pubmed: 34548567
Oncotarget. 2017 Jul 25;8(30):49671-49679
pubmed: 28572531
Lancet Respir Med. 2021 Oct;9(10):1154-1164
pubmed: 34166627
Adv Drug Deliv Rev. 2013 Nov;65(13-14):1866-79
pubmed: 24120656
N Engl J Med. 2020 Jan 2;382(1):41-50
pubmed: 31751012
BMC Cancer. 2018 May 4;18(1):527
pubmed: 29728089
Nat Rev Clin Oncol. 2018 Nov;15(11):694-708
pubmed: 30108370
Clin Cancer Res. 2016 Oct 1;22(19):4837-4847
pubmed: 27252416
N Engl J Med. 2022 Jan 20;386(3):241-251
pubmed: 34534430
Lancet. 2017 Jan 21;389(10066):255-265
pubmed: 27979383
Lung Cancer. 2019 Feb;128:33-39
pubmed: 30642450
J Thorac Oncol. 2016 Jan;11(1):e1-4
pubmed: 26762749
Thorac Cancer. 2020 Mar;11(3):511-518
pubmed: 31989769
Transl Lung Cancer Res. 2021 Aug;10(8):3659-3670
pubmed: 34584864
Clin Cancer Res. 2010 Dec 1;16(23):5873-82
pubmed: 21030498
Sci Rep. 2017 Mar 23;7:45193
pubmed: 28332624
Nat Commun. 2016 Jun 10;7:11815
pubmed: 27283993
JCO Precis Oncol. 2019;3:
pubmed: 31157314
Lancet Oncol. 2020 Mar;21(3):373-386
pubmed: 32027846
Ann Transl Med. 2018 Dec;6(23):446
pubmed: 30603634
JAMA. 2014 Apr 9;311(14):1430-7
pubmed: 24715074
Cancer Lett. 2016 Oct 1;380(2):494-504
pubmed: 27450722
Ann Oncol. 2019 Mar 1;30(3):447-455
pubmed: 30596880
J Thorac Oncol. 2018 Jul;13(7):968-977
pubmed: 29626621
Biochim Biophys Acta. 2010 Mar;1804(3):559-66
pubmed: 20026433
Front Oncol. 2021 Jul 09;11:709877
pubmed: 34307179
SLAS Technol. 2021 Feb;26(1):42-54
pubmed: 32659150
J Thorac Oncol. 2022 Jan;17(1):103-115
pubmed: 34455067
Cancer Sci. 2022 Feb;113(2):709-720
pubmed: 34855271
Int J Cancer. 2019 Sep 1;145(5):1432-1444
pubmed: 30784054
Lung Cancer. 2020 Dec;150:62-69
pubmed: 33070053
J Mol Diagn. 2021 Apr;23(4):495-505
pubmed: 33486072
Nat Cancer. 2022 Apr;3(4):402-417
pubmed: 35422503
Transl Lung Cancer Res. 2020 Dec;9(6):2599-2617
pubmed: 33489821
Clin Cancer Res. 2009 Aug 1;15(15):4829-37
pubmed: 19622585
N Engl J Med. 2005 Feb 24;352(8):786-92
pubmed: 15728811
Nat Rev Clin Oncol. 2018 Feb;15(2):81-94
pubmed: 29115304
Asian J Pharm Sci. 2020 Jan;15(1):26-41
pubmed: 32175016
PLoS One. 2019 Dec 20;14(12):e0226853
pubmed: 31860648
J Clin Oncol. 2022 Mar 1;40(7):710-718
pubmed: 34843401
Int J Pharm. 2014 Aug 25;471(1-2):245-57
pubmed: 24858386
Int J Clin Oncol. 2015 Aug;20(4):674-9
pubmed: 25336382
J Clin Oncol. 2022 Mar 1;40(7):719-728
pubmed: 35073148
J Clin Oncol. 2020 Feb 20;38(6):538-547
pubmed: 31809241
Onco Targets Ther. 2019 Dec 19;12:11305-11311
pubmed: 31908495
ESMO Open. 2021 Apr;6(2):100060
pubmed: 33647598
Clin Pharmacol Ther. 2014 Jan;95(1):15-23
pubmed: 24091716
J Thorac Oncol. 2018 Sep;13(9):e169-e172
pubmed: 30166014
J Clin Oncol. 2018 Sep 10;36(26):2702-2709
pubmed: 30059262
J Thorac Oncol. 2015 Jun;10(6):910-23
pubmed: 25658629
Thorac Cancer. 2020 Sep;11(9):2389-2397
pubmed: 32677256
J Thorac Oncol. 2017 Nov;12(11):1723-1727
pubmed: 28662863
ESMO Open. 2022 Feb;7(1):100395
pubmed: 35149428
Cells. 2019 Mar 31;8(4):
pubmed: 30935108
Cancers (Basel). 2019 Jul 01;11(7):
pubmed: 31266248
J Clin Oncol. 2020 Dec 1;38(34):4076-4085
pubmed: 33021871
Eur Respir Rev. 2014 Sep;23(133):356-66
pubmed: 25176972
JAMA Oncol. 2021 Dec 01;7(12):e214761
pubmed: 34647988
N Engl J Med. 2017 Feb 16;376(7):629-640
pubmed: 27959700
Cancers (Basel). 2021 Jun 08;13(12):
pubmed: 34201252
Oncogene. 2019 Jan;38(4):455-468
pubmed: 30111817
J Thorac Oncol. 2009 Jun;4(6):684-8
pubmed: 19404216
JAMA Oncol. 2020 Jul 1;6(7):1048-1054
pubmed: 32463456
Cancers (Basel). 2021 Mar 02;13(5):
pubmed: 33801379
Int J Cancer. 2019 Jun 1;144(11):2887-2896
pubmed: 30485437
Clin Lung Cancer. 2018 Nov;19(6):518-530.e7
pubmed: 30279111
Clin Drug Investig. 2018 Oct;38(10):983-987
pubmed: 30151614
Thorac Cancer. 2021 Jun;12(11):1708-1715
pubmed: 33943009
J Clin Oncol. 2005 May 10;23(14):3227-34
pubmed: 15886310
J Neurooncol. 2017 Nov;135(2):413-418
pubmed: 28780743
J Clin Oncol. 2017 Sep 10;35(26):3065-3074
pubmed: 28498782
Int J Cancer. 2006 Sep 15;119(6):1491-4
pubmed: 16642476
Clin Cancer Res. 2019 Jun 1;25(11):3341-3351
pubmed: 30796031
Clin Cancer Res. 2020 Jun 1;26(11):2654-2663
pubmed: 31911548
Oncoimmunology. 2017 Jul 26;6(11):e1356145
pubmed: 29147605
Cancer Res. 2015 Jun 15;75(12):2489-500
pubmed: 25870145
J Thorac Oncol. 2021 Nov;16(11):1909-1924
pubmed: 34311108
Ann Oncol. 2016 Mar;27(3):423-9
pubmed: 26768165
J Thorac Oncol. 2016 May;11(5):613-638
pubmed: 27013409
J Clin Oncol. 2020 Jun 18;:JCO1903123
pubmed: 32552277
Nature. 2016 May 25;534(7605):129-32
pubmed: 27251290
Cell Res. 2005 Mar;15(3):212-7
pubmed: 15780185
J Clin Oncol. 2018 Aug 20;36(24):2532-2537
pubmed: 29989854
Lung Cancer. 2018 Jan;115:21-27
pubmed: 29290257
Chemother Res Pract. 2014;2014:856156
pubmed: 25548673
J Thorac Oncol. 2021 Jun;16(6):1017-1029
pubmed: 33676017
Acta Cytol. 2019;63(6):489-496
pubmed: 30566947
Cancer. 2013 Dec 15;119(24):4325-32
pubmed: 24105277
Sci Rep. 2021 Aug 9;11(1):16122
pubmed: 34373555
Cancers (Basel). 2020 Dec 22;13(1):
pubmed: 33374971
J Thorac Oncol. 2018 Sep;13(9):1415-1421
pubmed: 29857056
Clin Lung Cancer. 2022 Mar;23(2):e131-e134
pubmed: 34548228
Eur J Pharm Sci. 2016 Jan 1;81:162-71
pubmed: 26517962
J Thorac Oncol. 2015 Dec;10(12):1713-9
pubmed: 26334752
J Cancer Res Clin Oncol. 2020 Sep;146(9):2427-2433
pubmed: 32385709
J Clin Oncol. 2020 Aug 20;38(24):2753-2761
pubmed: 32614698
N Engl J Med. 2005 Jul 14;353(2):133-44
pubmed: 16014883
Cell. 2009 Jul 10;138(1):51-62
pubmed: 19576624
Nat Genet. 2017 Dec;49(12):1693-1704
pubmed: 29106415
Br J Cancer. 2019 Oct;121(9):725-737
pubmed: 31564718
J Thorac Oncol. 2017 Feb;12(2):403-407
pubmed: 27765535
J Thorac Oncol. 2013 Feb;8(2):179-84
pubmed: 23328547
Front Oncol. 2018 Jul 03;8:208
pubmed: 30018881
Ann Oncol. 2009 Apr;20(4):696-702
pubmed: 19088172
Lung Cancer. 2017 Jun;108:228-231
pubmed: 28625641
Ann Oncol. 2016 Feb;27(2):281-6
pubmed: 26598547
World J Surg Oncol. 2021 May 8;19(1):145
pubmed: 33964931
Nat Rev Clin Oncol. 2022 Jan;19(1):51-69
pubmed: 34561632
Oncogene. 2019 Jan;38(5):656-670
pubmed: 30171258
Ann Oncol. 2020 Jun;31(6):789-797
pubmed: 32240796
Cancer. 2018 Jan 1;124(1):105-109
pubmed: 28940498
Clin Cancer Res. 2018 Jul 1;24(13):3097-3107
pubmed: 29506987
Cancer Discov. 2013 Dec;3(12):1355-63
pubmed: 24078774
J Thorac Oncol. 2019 Sep;14(9):e201-e202
pubmed: 31445736
Mol Oncol. 2021 Jun;15(6):1617-1621
pubmed: 34075709
Front Oncol. 2021 Apr 15;11:649843
pubmed: 33937055
Cell Death Dis. 2017 Oct 26;8(10):e3141
pubmed: 29072692
Cell. 2019 Apr 4;177(2):414-427.e13
pubmed: 30951669
Lancet Respir Med. 2021 Aug;9(8):829-839
pubmed: 33780662
N Engl J Med. 2020 Jun 18;382(25):2419-2430
pubmed: 32469182
Lung Cancer. 2019 May;131:78-85
pubmed: 31027702
Clin Cancer Res. 2015 Sep 1;21(17):3924-33
pubmed: 25964297
JAMA Oncol. 2018 Nov 1;4(11):1527-1534
pubmed: 30073261
Int J Mol Sci. 2019 Aug 14;20(16):
pubmed: 31416192